DAA-1106

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. It has anxiolytic effects in animal studies.

DAA-1106 has a sub-nanomolar binding affinity (K i ) of 0.28 nM, and has been used extensively in its 3 H or 11 C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. DAA-1106 is used in combination with positron emission tomography (PET) scanning to examine neuroinflammation in vivo.

DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. It has anxiolytic effects in animal studies.

DAA-1106 has a sub-nanomolar binding affinity (K i ) of 0.28 nM, and has been used extensively in its 3 H or 11 C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. DAA-1106 is used in combination with positron emission tomography (PET) scanning to examine neuroinflammation in vivo.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370854434 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.